AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.02
+1.20 (9.36%)
Aug 25, 2026, 4:00 PM EDT - Market closed
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 62 employees as of December 31, 2025. The number of employees increased by 4 or 7.27% compared to the previous year.
Employees
62
Change (1Y)
4
Growth (1Y)
7.27%
Revenue / Employee
n/a
Profits / Employee
-$1,503,706
Market Cap
690.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 62 | 4 | 7.27% |
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | 33 | 3,300.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Phathom Pharmaceuticals | 371 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| MapLight Therapeutics | 133 |
| OmniAb | 89 |
| Prelude Therapeutics | 79 |
| Zevra Therapeutics | 61 |
AGMB News
- 1 day ago - Agomab initiated with an Overweight at Piper Sandler - TheFly
- 6 days ago - Agomab initiated with an Overweight at Cantor Fitzgerald - TheFly
- 6 days ago - Agomab initiated with an Overweight at Cantor Fitzgerald - TheFly
- 19 days ago - AgomAb Therapeutics NV Earnings release: Q2 2026 - Filings
- 4 weeks ago - Agomab initiated with a Buy at B. Riley - TheFly
- 2 months ago - Agomab Therapeutics NV trading resumes - TheFly
- 2 months ago - Agomab Therapeutics NV trading halted, volatility trading pause - TheFly
- 2 months ago - Agomab announces NOV-ERA study design - TheFly